Muscle-specific Pten deletion protects against insulin resistance and diabetes
- PMID: 15657439
- PMCID: PMC544010
- DOI: 10.1128/MCB.25.3.1135-1145.2005
Muscle-specific Pten deletion protects against insulin resistance and diabetes
Abstract
Pten (phosphatase with tensin homology), a dual-specificity phosphatase, is a negative regulator of the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway. Pten regulates a vast array of biological functions including growth, metabolism, and longevity. Although the PI3K/Akt pathway is a key determinant of the insulin-dependent increase in glucose uptake into muscle and adipose cells, the contribution of this pathway in muscle to whole-body glucose homeostasis is unclear. Here we show that muscle-specific deletion of Pten protected mice from insulin resistance and diabetes caused by high-fat feeding. Deletion of muscle Pten resulted in enhanced insulin-stimulated 2-deoxyglucose uptake and Akt phosphorylation in soleus but, surprisingly, not in extensor digitorum longus muscle compared to littermate controls upon high-fat feeding, and these mice were spared from developing hyperinsulinemia and islet hyperplasia. Muscle Pten may be a potential target for treatment or prevention of insulin resistance and diabetes.
Figures
Similar articles
-
Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.Mol Cell Biol. 2005 Mar;25(6):2498-510. doi: 10.1128/MCB.25.6.2498-2510.2005. Mol Cell Biol. 2005. PMID: 15743841 Free PMC article.
-
PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.Mol Biol Cell. 2012 Oct;23(19):3882-98. doi: 10.1091/mbc.E12-05-0337. Epub 2012 Aug 8. Mol Biol Cell. 2012. PMID: 22875989 Free PMC article.
-
Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.Mol Endocrinol. 2001 Aug;15(8):1411-22. doi: 10.1210/mend.15.8.0684. Mol Endocrinol. 2001. PMID: 11463863
-
Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.Pharmacol Ther. 2006 Dec;112(3):799-809. doi: 10.1016/j.pharmthera.2006.06.001. Epub 2006 Jul 13. Pharmacol Ther. 2006. PMID: 16842857 Review.
-
PTEN, Insulin Resistance and Cancer.Curr Pharm Des. 2017;23(25):3667-3676. doi: 10.2174/1381612823666170704124611. Curr Pharm Des. 2017. PMID: 28677502 Review.
Cited by
-
Redox Regulation of PTEN by Reactive Oxygen Species: Its Role in Physiological Processes.Antioxidants (Basel). 2024 Feb 4;13(2):199. doi: 10.3390/antiox13020199. Antioxidants (Basel). 2024. PMID: 38397797 Free PMC article. Review.
-
Analysis of circRNA and miRNA expression profiles in IGF3-induced ovarian maturation in spotted scat (Scatophagus argus).Front Endocrinol (Lausanne). 2022 Nov 25;13:998207. doi: 10.3389/fendo.2022.998207. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506051 Free PMC article.
-
PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels.Front Endocrinol (Lausanne). 2022 Feb 25;13:850214. doi: 10.3389/fendo.2022.850214. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35282439 Free PMC article.
-
Nucleus Type-Specific DNA Methylomics Reveals Epigenetic "Memory" of Prior Adaptation in Skeletal Muscle.Function (Oxf). 2021 Aug 5;2(5):zqab038. doi: 10.1093/function/zqab038. eCollection 2021. Function (Oxf). 2021. PMID: 34870208 Free PMC article.
-
MOTS-c reduces myostatin and muscle atrophy signaling.Am J Physiol Endocrinol Metab. 2021 Apr 1;320(4):E680-E690. doi: 10.1152/ajpendo.00275.2020. Epub 2021 Feb 8. Am J Physiol Endocrinol Metab. 2021. PMID: 33554779 Free PMC article.
References
-
- Backman, S., V. Stambolic, and T. Mak. 2002. Pten function in mammalian cell size regulation. Curr. Opin. Neurobiol. 12:516-522. - PubMed
-
- Backman, S. A., D. Ghazarian, K. So, O. Sanchez, K. U. Wagner, L. Hennighausen, A. Suzuki, M. S. Tsao, W. B. Chapman, V. Stambolic, and T. W. Mak. 2004. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc. Natl. Acad. Sci. USA 101:1725-1730. - PMC - PubMed
-
- Backman, S. A., V. Stambolic, A. Suzuki, J. Haight, A. Elia, J. Pretorius, M. S. Tsao, P. Shannon, B. Bolon, G. O. Ivy, and T. W. Mak. 2001. Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29:396-403. - PubMed
-
- Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559-569. - PubMed
-
- Butler, M., R. A. McKay, I. J. Popoff, W. A. Gaarde, D. Witchell, S. F. Murray, N. M. Dean, S. Bhanot, and B. P. Monia. 2002. Specific inhibition of Pten expression reverses hyperglycemia in diabetic mice. Diabetes 51:1028-1034. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
